Сердечно-сосудистые заболевания, кардиореабилитация и сексуальная активность. Часть II. Частные вопросы и ингибиторы фосфодиэстеразы типа 5

1. Бубнова М.Г., Аронов Д.М. Сердечно-сосудистые заболевания, кардиореабилитация и сексуальная активность. Часть I: общие рекомендации и сердечно-сосудистые препараты. CardioСоматика (Кардиосоматика). 2012; 3.
2. Levine GN, Steinke EE, Bakaeen FG et al. Sexual activity and cardiovascular disease a scientific statement from the American Heart Association. Circulation 2012; 125: 1058–72.
3. Бубнова М.Г., Аронов Д.М., Оганов Р.Г., Рудоманов О.Г. (От имени участников исследования). Новые возможности Триметазидина МВ в лечении ишемической болезни сердца в условиях реальной клинической практики. Результаты Российского многоцентрового рандомизированного исследования «ПЕРСПЕКТИВА» (часть II). Кардиоваскулярная терапия и профилактика. 2011; 6: 70–80.
4. Belardinelli R, Purcaro A. Effect of Trimetazidine on the contractile response of chronically dysfunctional myocardium to long-dose dobutamine in ischaemic cardiomyopathology. Eur Heart J 2001; 22 (23): 2164–70.
5. Kostis JB, Jackson G, Rosen R et al. R. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005; 96: 313–21.
6. Antman EM, Anbe DT, Armstrong PW еt al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 2004; 110: e82–e292.
7. Tuttle WB, Cook WL, Fitch E. Sexual behavior in postmyocardial infarction patients Am J Cardiol 1994; 13: 140–53.
8. Бубнова М.Г., Сеченова Е.В., Аронов Д.М. Оценка эффективности ранней комплексной постстационарной реабилитации больных коронарной болезнью сердца после вмешательств на коронарных сосудах на диспансерно-поликлиническом этапе. Эффективная фармакотерапия в кардиологии и ангиологии. 2011; 1: 86–91.
9. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA 2011; 305: 1225–33.
10. Muller JE, Mittleman MA, Maclure M et al. Determinants of Myocardial Infarction Onset Study Investigators. Triggering myocardial infarction by sexual activity: low absolute risk and prevention by regular physical exertion. JAMA 1996; 275: 1405–9.
11. Mouller J, Ahlbom A, Hulting J et al. Sexual activity as a trigger of myocardial infarction: a case-crossover analysis in the Stockholm Heart Epidemiology Programmer (SHEEP). Heart 2001; 86: 387–90.
12. DeBusk RF, Blomqvist CG, Kouchoukos NT et al. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med 1986; 314: 161–6.
13. Papadopoulos C, Shelley SI, Piccolo M et al. Sexual activity after coronary bypass surgery. Chest 1986; 90: 681–5.
14. Lukkarinen H, Lukkarinen O. Sexual satisfaction among patients after coronary bypass surgery or percutaneous transluminal angioplasty: eight-year follow-up. Heart Lung 2007; 36: 262–9.
15. Rastogi S, Rodriguez JJ, Kapur V, Schwarz ER. Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem. Int J Impot Res 2005; 17 (Suppl. 1): S25–S36.
16. Jaarsma T. Sexual problems in heart failure patients. Eur J Cardiovasc Nurs 2002; 1: 61–7.
17. Schwarz ER, Kapur V, Bionat S et al. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res 2008; 20: 85–91.
18. Flynn KE, Pin˜a IL, Whellan DJ et al. HF-ACTION Investigators. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial [published correction appears in JAMA 2009; 301: 1451–9; 302: 2322.
19. Belardinelli R, Lacalaprice F, Faccenda E et al. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure. Int J Cardiol 2005; 101: 83–90.
20. Jaarsma T, Dracup K, Walden J, Stevenson LW. Sexual function in patients with advanced heart failure. Heart Lung 1996; 25: 262–70.
21. Stanek EJ, Oates MB, McGhan WF et al. Preferences fortreatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail 2000; 6: 225–32.
22. Heidbuchel H, Panhuyzen-Goedkoop N, Corrado D et al. Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions, part I: supraventricular arrhythmias and pacemakers. Eur J Cardiovasc Prev Rehabil 2006; 13: 475–84.
23. Heidbuchel H, Corrado D, Biffi A et al. Study Group on Sports Cardiology of the European Association for Cardiovascular Prevention and Rehabilitation. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions, part II: ventricular arrhythmias, channelopathies and implantable defibrillators. Eur J Cardiovasc Prev Rehabil 2006; 13: 676–86.
24. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference and the European Society of Cardiology Consensus Recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008; 52: 1990–6.
25. Kavanagh T, Shephard RJ. Sexual activity after myocardial infarction. Can Med Assoc J 1977; 116: 1250–3.
26. Fries R, Konig J, Schafers HJ, Bohm M. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol 2002; 25: 474–8.
27. Steinke EE. Sexual concerns of patients and partners after an implantable cardioverter defibrillator. Dimens Crit Care Nurs 2003; 22: 89–96.
28. Steinke EE, Gill-Hopple K, Valdez D, Wooster M. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 2005; 34: 299–308.
29. Vazquez LD, Sears SF, Shea JB, Vazquez PM. Sexual health for patients with an implantable cardioverter defibrillator. Circulation 2010; 122: e465–e7.
30. Steinke EE, Gill-Hopple K, Valdez D, Wooster M. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 2005; 34: 299–308.
31. Sears SF, Kovacs AH, Conti JB, Handberg E. Expanding the scope of practice for cardiac rehabilitation: managing patients with implantable cardioverter defibrillators. J Cardiopulm Rehabil 2004; 24: 209–15.
32. Maron BJ, Doerer JJ, Haas TS et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 2009; 119: 1085–92.
33. Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010; 121: 445–56.
34. Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol 2005; 45: 1334–40.
35. Vigl M, Kaemmerer M, Seifert-Klauss V et al. Contraception in women with congenital heart disease. Am J Cardiol 2010; 106: 1317–21.
36. Vigl M, Hager A, Bauer U et al. Sexuality and subjective wellbeing in male patients with congenital heart disease. Heart 2009; 95: 1179–83.
37. Верткин А.Л., Пушкарь Д.Ю., Тополянский А.В., Сегал А.С. Эректильная дисфункция. Лечащий врач. 2003; 7: 1–7.
38. Верткин А.А., Пушкарь Д.Ю., Долаберидзе Д.З., Полупанова Ю.С. Современные представления об эректильной дисфункции и новые методы ее лечения. Кардиоваскулярная терапия и профилактика. 2005; 4 (3): 101–12.
39. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol 1999; 83: 21C–28C.
40. Kloner RA, Hutter AM, Emmick JT et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003; 42: 1855–60.
41. Kloner RA. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation 2004; 110: 3149–55.
42. Kloner R. Erectile dysfunction and hypertension. Int J Impot Res 2007; 19: 296–302.
43. Kapur V, Chien CV, Fuess JE, Schwarz ER. The relationship between erectile dysfunction and cardiovascular disease. The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease. Rev Cardiovasc Med 2008; 9 (3): 187–95.
44. Верткин А.Л., Моргунов Л.Ю., Звягинцева Е.И. Левитра: многогранность действия, перспективы применения. CardioСоматика (Кардиосоматика). 2011; 2: 70–4.
45. Wespes E, Amar E, Eardley F et al. Сексуальная дисфункция у мужчин: эректильная дисфункция и преждевременная эякуляция. Рекомендации Европейской ассоциации урологов. Пер. М.Н.Климова.
46. Carson CC, Burnett AL, Levine LA et al. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology 2002; 60 (Suppl. 2B): 12–27.
47. Padma-Nathan H, Eardley I, Kloner RA et al. A 4-year update on the safety of sildenafil citrate (Viagra). Urology 2002; 60 (Suppl. 2B): 67–90.
48. Conti CR, Pepine CJ, Sweeney M. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in the patients with ischemic heart disease. Am J Cardiol 1999; 83: 29C–34C.
49. Hermann HC, Chang G, Klugherz BD et al. Hemodynamic effect of sildenafil in men with severe coronary artery disease. N Engl J Med 2000; 342: 1622–6.
50. Arruda-Olson AM, Mahoney DW, Nehra A et al. Cardiovascular effects of sildenafil during exercise in man with known or probable coronary artery disease: a randomized crossover trial. JAMA 2002; 287: 719–25.
51. Beavo JA. Cyclic nucleotide phosphodiesterases functional implications of multiple isoforms. Physiol Rev 1995; 75: 725–48.
52. Карпов Ю.А. Лечение эректильной дисфункции у больных с сердечно-сосудистыми заболеваниями: от обсуждения безопасности к потенциально благоприятным эффектам. Кардиология. 2004; 1: 83–7.
53. Halcox JP, Nour KR, Zalos G et al. The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia. J Am Coll Cardiol 2002; 40: 1232–40.
54. Kriston L, Gunzler C, Agyemang A et al. SPARK Study Group. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation: findings of the SPARK project in 493 patients. J Sex Med 2010; 7: 2044–55.
55. Friedman S. Cardiac disease, anxiety, and sexual functioning. Am J Cardiol 2000; 86: 46F–50F.
56. Moser DK, Dracup K, Evangelista LS et al. Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung 2010; 39: 378–85.
57. Roose SP, Seidman SN. Sexual activity and cardiac risk: is depression a contributing factor? Am J Cardiol 2000; 86: 38F–40F.
58. Lai YH, Hsieh SR, Ho WC, Chiou AF. Factors associated with sexual quality of life in patients before and after coronary artery bypass grafting surgery. J Cardiovasc Nurs 2011; 26: 487–96.
59. Phan A, Ishak WW, Shen BJ et al. Persistent sexual dysfunction impairs quality of life after cardiac transplantation. J Sex Med 2010; 7: 2765–73.
60. Nicolosi A, Moreira ED Jr, Villa M, Glasser DB. A population study of the association between sexual function, sexual satisfaction and depressive symptoms in men. J Affect Disord 2004; 82: 235–43.

М.Г.Бубнова*, Д.М.Аронов

ФГБУ Государственный научно-исследовательский центр профилактической медицины Минздрава РФ, Москва
*mbubnova@gnicpm.ru

________________________________________________

M.G.Bubnova*, D.M.Aronov

State Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moscow
*mbubnova@gnicpm.ru